Journal of Molecular Medicine 2025

3 papers
The 2025 edition of the Journal of Molecular Medicine highlights research into the therapeutic applications of mesenchymal stem cells (MSCs) and the regulatory mechanisms of ferroptosis. A primary focus involves the use of MSC-derived exosomes to address spinal cord injury, specifically examining how AKAP12 inhibits STAT3 and ERK signaling pathways to reduce neuronal cell death. This work is complemented by broader reviews on the role of mesenchymal stem cells in treating various ferroptosis-related diseases. Another prominent theme in this year's publications is the study of DNA-RNA hybrids and their involvement in inflammatory responses. Research explores the biological sources of these hybrids and their implications for immune system modulation and therapeutic intervention. Prolific authors contributing to these developments include Chuhan Ke, Fan Wang, and Hanlin Zheng. Collectively, the research from 2025 emphasizes molecular signaling and cellular therapies as key areas for understanding and treating inflammatory and degenerative conditions.

Papers

Title
Application of mesenchymal stem cells in ferroptosis-related diseases
BMSCs-derived exosomal AKAP12 alleviates neuronal cell ferroptosis by inhibiting the STAT3 and ERK signaling pathways in spinal cord injury
DNA-RNA hybrids in inflammation: sources, immune response, and therapeutic implications